World Botulism Pipeline Review, H1 2017 Featuring 7 Key Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Botulism - Pipeline Review, H1 2017" report to their offering.

This report provides comprehensive information on the therapeutic development for Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Botulism and special features on late-stage and discontinued projects.

Botulism is a rare but serious illness. The cause is a toxin (poison) made by a bacterium called Clostridium botulinum. It occurs naturally in soil. Food borne botulism comes from eating foods contaminated with the toxin. Symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, and muscle weakness. Treatment may include antitoxins, intensive medical care, or surgery of infected wounds.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Botulism Overview
  3. Therapeutics Development
  4. Pipeline Products for Botulism - Overview
  5. Pipeline Products for Botulism - Comparative Analysis
  6. Botulism - Therapeutics under Development by Companies
  7. Botulism - Therapeutics under Investigation by Universities/Institutes
  8. Botulism Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Botulism - Products under Development by Companies
  13. Botulism - Products under Investigation by Universities/Institutes
  14. Botulism - Companies Involved in Therapeutics Development
  • CytoDel LLC
  • Hawaii Biotech Inc
  • Medy-Tox Inc
  • Microbiotix Inc
  • Nanotherapeutics Inc
  • Planet Biotechnology Inc
  • XOMA Corp

For more information about this report visit http://www.researchandmarkets.com/research/2jmzc2/botulism

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs